Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
Regulators in the UK are turning up the heat on crypto perpetual contracts. The latest wave centers on Hyperliquid an...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
As July 2026 unfolds, the two JPMorgan income ETFs clash over safety versus yield. This piece weighs performance, pay...
The rental market is shifting: entry-level homes are harder to find, and renters struggle to afford them. This guide ...
Start your weekend with a clear read on the investing landscape. This Friday Reads collection distills practical idea...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
A five-month surge has transformed a $10,000 stake in XLK into roughly $13,450, outpacing the S&P 500 and signaling A...
A high-profile family quarrel during anniversary week highlights how money, branding, and personal ties intersect in ...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
Kick back this weekend with 10 thoughtful weekend reads that bridge big ideas and real-world investing. Each piece of...